Integral Molecular’s SARS-CoV-2 Reporter Virus Particles (RVPs) are replication-incompetent pseudotyped virus particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation. SARS-CoV-2 RVPs display antigenically correct spike protein on a heterologous virus core and carry a modified genome that expresses a convenient optical reporter gene within 24 hours of cellular infection. Protocols are provided for neutralization and infectivity assays.
Target cells are sold separately.
Product | SARS-CoV-2 Reporter Virus Particles (RVPs) |
Catalog Number | RVP-702 |
Strain | D614G |
Packaging | 20% FBS/DMEM |
Recommended Input Range | 10-15 uL per well (96-well plate) using the 293T-ACE2 stable cell line |
Target Cell Line | 293T-hsACE2 Clonal Cell Line (Cat# C-HA102) |
Mutations (compare to GenBank QHD43416.1) |
D614G |
Lead time | Ready to ship |
Shipping | Shipped on dry ice |
Storage conditions | Store at -80°C (+/- 10°C) upon receipt |
Size | 1.0 mL/vial |
Warranty | Terms and Conditions (pdf) |
SDS | SARS-CoV-2 RVP SDS (pdf) |
Protocols | |
Technical Data Sheets | SARS-CoV-2 Tech Data Sheets |